Intelligence Platform
Patents
Browse 738 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10633632
Human disc tissue
granted patentUS 10633351
Halogenated compound and axially chiral isomer thereof
granted patentUS 10626096
Azole derivatives as apelin receptor agonist
granted patentUS 10626129
Heteroaryl inhibitors of PDE4
granted patentUS 10626094
Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof
granted patentUS 10617673
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders,
granted patentUS 10617723
C. novyi for the treatment of solid tumors in humans
granted patentUS 10611760
Therapeutic compounds as inhibitors of the orexin-1 receptor
granted patentUS 10597367
Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof
granted patentUS 10590082
N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of gluco
granted patentUS 10590093
1,2,4-oxadiazole derivatives as immunomodulators
granted patentUS 10589997
Discrete carbon nanotubes with targeted oxidation levels and stable gel formulations there
granted patentUS 10584103
Small molecule agonists of neurotensin receptor 1
granted patentUS 10577406
FKBP-L polypeptides and uses in angiogenesis-mediated disorders
granted patentUS 10570128
Agonists of the apelin receptor and methods of use thereof
granted patentUS 10556897
Protein kinase inhibitors
granted patentUS 10556890
Heteroaryl compounds and methods of use thereof
granted patentUS 10548883
Benzotriazole-derived Ξ± and Ξ²-unsaturated amide compound used as TGF-Ξ² RI inhibitor
granted patentUS 10544188
Inhibitor of apoptosis protein (IAP) antagonists
granted patentUS 10532986
Cyclic compound acting as PDE4 inhibitor
granted patentUS 10519133
Vinyl compounds as FGFR and VEGFR inhibitors
granted patentUS 10508103
Benzimidazole-linked indole compound acting as novel divalent IAP antagonist
granted patentUS 10500175
Compositions and methods for the treatment of cancer
granted patentUS 10500246
Compositions for delivery to and treatment of atherosclerotic plaques
granted